An FDA advisory committee (ODAC) voted 12-0 today in favor of a major shift in how the agency evaluates new treatments for multiple myeloma. If approved by the FDA, the result will be faster approval of new treatments for multiple myeloma.
Annual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% – mainly among men in low- and middle-income countries. A commissioned report in The Lancet seeks to guide cancer experts worldwide on how to manage this massive influx of prostate cancer patients.
Can we eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A new study shows the feasibility of offering high-risk communities free, accessible testing and treatment for H.pylori infection – a major risk factor for gastric cancer.
B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according to a new study led by Gil Yosipovitch, M.D., director of the Miami Itch Center, and Santosh Mishra, Ph.D., a neuroscientist and associate professor at the North Carolina State College of Veterinary Medicine.
Dr. Alan J. Wein’s long history of mentoring students and fellow faculty has been recognized by the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction.
Desai Sethi Urology Institute (DSUI) Scientific Director Nima Sharifi, M.D., authored an invited commentary in JAMA Network Open related to a new Million Veteran Program study on the HSD3B1 genotype, an allele he helped discover more than 10 years ago.
Researchers at Sylvester Comprehensive Cancer Center have received two new three-year, $1 million grants from the U.S. Department of Defense to study endometrial cancer in Black women who were born in the U.S., the Caribbean and West Africa.
A transformative gift to expand research and breakthrough therapies, an upcoming conference on managing neuroendocrine tumors, FDA approval of Imetelstat for patients with anemia from myelodysplastic syndromes and a researcher advocating for making bereavement care a public health priority are all included in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Bereaved persons are at greater risk for many adverse outcomes, including mental health challenges, health care neglect, cancer, heart disease, suicide, and death.
Sylvester Comprehensive Cancer Center and the North American Neuroendocrine Tumor Society will present a regional educational conference on April 6 focusing on neuroendocrine tumors (NET) and the latest knowledge for optimal NET management.
The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.
A guitarist begins 2024 on high note after awake brain surgery, Dr. Damian Green named chief of Transplantation & Cellular Therapy, targeting treatment resistance in CLL, expanding the patient pool for immunotherapy, researching potential new treatments for head and neck cancer, and more are included in this month’s tip sheet.
Prominent oncologist and researcher Damian Green, M.D., is joining Sylvester Comprehensive Cancer Center as chief of the Division of Transplantation & Cellular Therapy. A specialist in multiple myeloma and other B-cell malignancies, his research has led to the discovery and testing of several pioneering immunotherapy approaches to treat myeloma and other blood cancers.
Three leading Florida academic cancer centers – Sylvester Comprehensive Cancer Center at the University of Miami Health System, Moffitt Cancer Center and the University of Florida Health Cancer Center – have joined to fund thousands of dollars for four projects statewide to help people detect and treat cancer early.
New research has identified a next-generation BTK degrader that could help overcome treatment resistance in CLL and related blood cancers.
Renowned urologists from leading academic centers shared their insights and clinical recommendations at Urology on the Beach, a three-day professional conference hosted by the Desai Sethi Urology Institute (DSUI) at the University of Miami Miller School of Medicine.
The Desai Sethi Institute of Urology (DSUI) at the University of Miami Miller School of Medicine unveiled the findings of its inaugural State of Urology survey and report today, which provides insights into the current landscape of urology and outlines implications for the future direction of the specialty.
Glioblastoma, an incurable brain cancer, is characterized by cells that can mimic human neurons, even growing axons and making active connections with healthy brain neurons.
Researchers with Sylvester Comprehensive Cancer Center have received funding to better understand how personalized nutrition and exercise programs can improve quality of life after cancer treatment.
A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Center has produced the first computational model for newly diagnosed multiple myeloma that predicts an individual’s personalized prognosis based on their tumor genomics and treatments.
Christian Nolen usually plays guitar on stage, but the professional guitarist recently underwent an open craniotomy and played notes from Deftones songs while a neurosurgical team worked to remove a tumor (glioma) from his brain. B-roll is available.
New research from Sylvester Comprehensive Cancer Center indicates that providing prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Study appears Jan. 4, 2024, in Blood Cancer Discovery.
How interactions between tumor genes, microenvironment affect multiple myeloma treatment responses, a new AI technique could guide glioblastoma treatment, new research shows birth country a key risk factor in stomach cancer, how petrochemicals fuel cancer risk and more are included in this month’s tip sheet.
Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center, has been named a fellow of the National Academy of Inventors. Her inventions and innovative contributions in nanomedicine, mitochondria-targeted drug delivery, and platinum-based prodrugs help guide targeted therapies in cancer and other diseases.
Physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make presentations at the American Society of Hematology’s 2023 annual meeting Dec. 9-12. This tip sheet highlights several of those presentations.
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities. That’s the conclusion of a five-year analysis of results from the U.S. Lymphoma CAR-T Cell Consortium.
Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center say a new combination of antibody therapies produced a ‘surprisingly high’ response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma.
In a study led by researchers at Sylvester Comprehensive Cancer Center, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
New research conducted by investigators at Sylvester Comprehensive Cancer Center and collaborating cancer centers indicates that a new type of targeted therapy may offer new treatment options for patients living with advanced myelofibrosis, a bone marrow disorder. Study results will be shared at ASH 2023 in San Diego, Dec. 9-12.
A study led by researchers at Sylvester Comprehensive Cancer Center suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Downloadable video is available.
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.
A new study from researchers with Sylvester Comprehensive Cancer Center and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms.
The investigational procedure, done in collaboration with University of Pittsburgh Medical Center (UPMC), harvests testicular tissue containing stem cells in prepubertal boys who are about to undergo treatments for cancer or other conditions that might result in infertility.
The 'Safari and Science,' art exhibit at Sylvester Comprehensive Cancer Center opens Dec. 1. The exhibit blends photographs of Africa with the scientific research Sophia George, Ph.D., is conducting worldwide to control and prevent cancer in the Black community.
Researchers at Sylvester Comprehensive Cancer Center have found that country of birth – not just geographic region – is a key risk factor for gastric intestinal metaplasia, a precursor lesion of stomach cancer.
A new AI technique could guide real-time GBM treatment. Researchers are using MRI-guided radiation therapy that pairs daily MRIs with radiation treatment -- automatically tracing tumors in large MRI datasets.
A multicenter study led by researchers at Sylvester Comprehensive Cancer Center shows how interactions between tumor cells and immune components of the microenvironment can impact treatment responses and outcomes in patients newly diagnosed with multiple myeloma who undergo combination treatments that include targeted immunotherapy.
Macarena de la Fuente, MD, chief of neuro-oncology at Sylvester Comprehensive Cancer Center, has been elected to the Society of Neuro-Oncology (SNO)’s board of directors. She becomes the first Hispanic elected to the multidisciplinary board.
The Miami Dolphins and AutoNation have teamed up to fund a $1-million, four-year Breast Cancer Research Foundation project at Sylvester Comprehensive Cancer Center to investigate critical health disparities that drive mortality among breast cancer patients.
A researcher with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators have penned a commentary highlighting how petrochemicals are a major contributor to cancer risks, resulting in a profoundly negative impact on overall health.
Dr. Anastasia Santiago began her career in healthcare as a hospital unit secretary. Despite barriers and naysayers, the determined young woman went on to earn a doctorate as a nurse practitioner, and today is the advanced practice provider supervisor for Sylvester Comprehensive Cancer Center’s Division of Hematology.
Southwest Florida residents will soon have greater access to top-tier cancer care and clinical trials when Sylvester Comprehensive Cancer Center opens its Naples office on Nov. 1.
Oct. Tipsheet - Sylvester’s top leader receives prestigious award, a pioneering physician is elected to the Neuro-Oncology Society’s board, an NCI grant funds research into lifestyle interventions for breast cancer patients, breast cancer and stress, teaming up with the Dolphins to battle breast cancer, physician burnout, more.
In a comprehensive review published in the Journal of the American College of Cardiology: Cardiovascular Interventions, Yiannis S. Chatzizisis, M.D., Ph.D., professor and chief of cardiovascular medicine at the University of Miami Miller School of Medicine, and colleagues show how artificial intelligence (AI), computational simulations and extended reality – collectively called AISER – are providing new tools to improve cardiovascular care.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
